Results 321 to 330 of about 115,987 (377)
Some of the next articles are maybe not open access.
Diabetes, obesity and metabolism, 2023
To determine the potential association between the use of either glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) or dipeptidyl peptidase‐4 (DPP‐4) inhibitors, and the risk of thyroid cancer in individuals with type 2 diabetes.
S. Bea +5 more
semanticscholar +1 more source
To determine the potential association between the use of either glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) or dipeptidyl peptidase‐4 (DPP‐4) inhibitors, and the risk of thyroid cancer in individuals with type 2 diabetes.
S. Bea +5 more
semanticscholar +1 more source
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Nature, 2013 Most human coronaviruses cause mild upper respiratory tract disease but may be associated with more severe pulmonary disease in immunocompromised individuals. However, SARS coronavirus caused severe lower respiratory disease with nearly 10% mortality and
V Stalin Raj +2 more
exaly +2 more sources
The Journal of pharmacy and pharmacology, 2021
OBJECTIVE To provide the scientific basis for the utility of rhizome of Trillium govanianum as nutraceutical supplements in managing physiological glycemic levels.
P. Suresh +3 more
semanticscholar +1 more source
OBJECTIVE To provide the scientific basis for the utility of rhizome of Trillium govanianum as nutraceutical supplements in managing physiological glycemic levels.
P. Suresh +3 more
semanticscholar +1 more source
Peptide Substrates of Dipeptidyl Peptidases
2006DPP IV has been attributed a large array of functions, some of which are mediated by its exopeptidase activity. Although it only removes two amino acid residues at the N-terminus of the peptide, this cleavage can inactivate or modify the activity of regulatory peptides, peptide hormones, chemokines and neuropeptides. Several excellent DPP IV substrates
Brandt, Inger +4 more
openaire +3 more sources
Dipeptidyl peptidase-4 inhibitors
Reactions Weekly, 2021The dipeptidyl peptidase 4 (DPP-4) inhibitor has become a popular anti-diabetes medication since its introduction in 2006. They are small molecules that specifically bind to the catalytic domain of DPP-4, which consequently prevents the enzymatic inactivation of incretin hormones (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide)
Yoo Hyung Kim, Young Min Cho
openaire +2 more sources
Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors
Bioorganic & Medicinal Chemistry Letters, 2006Using a dipeptide nitrile scaffold we have identified a potent and selective inhibitor of human dipeptidyl peptidase I.
Jon, Bondebjerg +4 more
openaire +2 more sources
Pathophysiological Implications of Dipeptidyl Peptidases
Current Protein & Peptide Science, 2017Dipeptidyl peptidases (DPPs) belong to one of the protease families classified under EC 3.4.14 in the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology. DPPs family consists of eight members in the mammalian species. They play a role in oligopeptide N-terminal processing and degradation of bioactive peptides.
Akira, Sato, Hisakazu, Ogita
openaire +2 more sources
Australasian Journal of Dermatology, 2020
There have been a number of case reports and small clinical series reporting the potential association between dipeptidyl peptidase‐4 inhibitors (DPPIs) for diabetes and the onset of bullous pemphigoid (BP).
K. Phan +2 more
semanticscholar +1 more source
There have been a number of case reports and small clinical series reporting the potential association between dipeptidyl peptidase‐4 inhibitors (DPPIs) for diabetes and the onset of bullous pemphigoid (BP).
K. Phan +2 more
semanticscholar +1 more source